Regenerative Potential of Stem and Progenitor Cells from Ischemic Testes of C57Bl/6 Mice in Culture and in the Model of Spermatogenesis Suppression Caused by Busulfan
- 作者: Skurikhin E.1, Pakhomova A.1, Pershina O.1, Ermolaeva L.1, Ermakova N.1, Krupin V.1, Pan E.1, Kudryashova A.1, Rybalkina O.1, Zhdanov V.1, Goldberg V.2, Dygai A.1
-
隶属关系:
- E. D. Goldberg Research Institute of Pharmacology and Regenerative Medicine
- Tomsk Research Medical Center
- 期: 卷 162, 编号 3 (2017)
- 页面: 400-405
- 栏目: Morphology and Pathomorphology
- URL: https://journals.rcsi.science/0007-4888/article/view/238256
- DOI: https://doi.org/10.1007/s10517-017-3625-1
- ID: 238256
如何引用文章
详细
The regenerative potential of stem and progenitor cells from ischemic testes of C57Bl/6 mice was studied in vitro (cell culture) and in vivo (mouse model of busulfan-induced suppression of spermatogenesis). Spermatogonial stem cells with phenotypes CD117—CD90+ and CD51—CD24+CD52+ from ischemic testes demonstrated 33-fold and 7-fold increments of cell mass and generated colonies in vitro. Epithelial (CD45—CD31—Sca-1+CD49f+) and endothelial (CD45—CD31+) precursors exhibited lower self-renewal capacity. On day 30 after injection of stem and progenitor cells from ischemic testes to the rete testis zone of the testes of busulfantreated animals, an increase in the count of CD117—CD90+ spermatogonial stem cells, total count, and mobile sperm count in the testes of recipient mice was observed. In addition, we observed an increase in Sca-1+ cell count, recovery of the spermatogenic epithelium in the seminiferous tubules, and appearance of immature Leydig cells in “busulfan” testes; the level of tissue testosterone and fertility index also increased.
作者简介
E. Skurikhin
E. D. Goldberg Research Institute of Pharmacology and Regenerative Medicine
Email: angelinapakhomova2011@gmail.com
俄罗斯联邦, Tomsk
A. Pakhomova
E. D. Goldberg Research Institute of Pharmacology and Regenerative Medicine
编辑信件的主要联系方式.
Email: angelinapakhomova2011@gmail.com
俄罗斯联邦, Tomsk
O. Pershina
E. D. Goldberg Research Institute of Pharmacology and Regenerative Medicine
Email: angelinapakhomova2011@gmail.com
俄罗斯联邦, Tomsk
L. Ermolaeva
E. D. Goldberg Research Institute of Pharmacology and Regenerative Medicine
Email: angelinapakhomova2011@gmail.com
俄罗斯联邦, Tomsk
N. Ermakova
E. D. Goldberg Research Institute of Pharmacology and Regenerative Medicine
Email: angelinapakhomova2011@gmail.com
俄罗斯联邦, Tomsk
V. Krupin
E. D. Goldberg Research Institute of Pharmacology and Regenerative Medicine
Email: angelinapakhomova2011@gmail.com
俄罗斯联邦, Tomsk
E. Pan
E. D. Goldberg Research Institute of Pharmacology and Regenerative Medicine
Email: angelinapakhomova2011@gmail.com
俄罗斯联邦, Tomsk
A. Kudryashova
E. D. Goldberg Research Institute of Pharmacology and Regenerative Medicine
Email: angelinapakhomova2011@gmail.com
俄罗斯联邦, Tomsk
O. Rybalkina
E. D. Goldberg Research Institute of Pharmacology and Regenerative Medicine
Email: angelinapakhomova2011@gmail.com
俄罗斯联邦, Tomsk
V. Zhdanov
E. D. Goldberg Research Institute of Pharmacology and Regenerative Medicine
Email: angelinapakhomova2011@gmail.com
俄罗斯联邦, Tomsk
V. Goldberg
Tomsk Research Medical Center
Email: angelinapakhomova2011@gmail.com
俄罗斯联邦, Tomsk
A. Dygai
E. D. Goldberg Research Institute of Pharmacology and Regenerative Medicine
Email: angelinapakhomova2011@gmail.com
俄罗斯联邦, Tomsk